← Eichor
Study identifier: NCT06345534 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

FAST-FORWARD vs HAI5

Condition: Cancer, Breast  ·  Sponsor: University Hospital, Ghent

PhaseNA
Planned participants740
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Randomized comparison between the FAST-FORWARD schedule and the HAI5 schedule for breast cancer radiotherapy in 5 fractions.

This description comes directly from the study's public registry record.

Talk to the study team

Liv Veldeman, MD, PhD  ·  09 332 30 15  ·  liv.veldeman@uzgent.be

Emma Van Damme  ·  09 332 19 53  ·  emma.vandamme@uzgent.be

Always discuss trial participation with your own doctor first.

Locations (2)

Universitary HospitalGhent, BelgiumNot Yet Recruiting
University Hospital GhentGhent, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06345534